Inactive Instrument

Press Releases Apyx Medical Corp Nasdaq

Equities

US03837C1062

Real-time Estimate Cboe BZX Other stock markets 10:08:42 03/06/2024 pm IST			5-day change	1st Jan Change
1.58 ^USD	-75.24%		+7.24%	+0.62%

09/05	Transcript : Apyx Medical Corporation, Q1 2024 Earnings Call, May 09, 2024
09/05	Stavros Vizirgianakis Enters into Letter Agreement with Apyx Medical	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Apyx: Q1 Earnings Snapshot	09/05	AQ
Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook	09/05	BU
Apyx Medical Corporation Announces Board Leadership Transition	09/05	BU
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024	25/04	BU
APYX MEDICAL CORPORATION SHOWCASES NEW DATA AND TREATMENT INSIGHTS AT THE RENUVION USERS' SUMMIT	12/04	AQ
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit	11/04	BU
APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS, INTRODUCES FULL YEAR 2024 FINANCIAL OUTLOOK	22/03	AQ
Apyx: Q4 Earnings Snapshot	21/03	AQ
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook	21/03	BU
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024	04/03	BU
APYX MEDICAL CORPORATION ANNOUNCES RENUVION TO BE FEATURED IN EDUCATIONAL SESSIONS AT THE AMERICAN ACADEMY OF COSMETIC SURGERY SCIENTIFIC MEETING	22/02	AQ
Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting	21/02	BU
APYX MEDICAL CORPORATION ANNOUNCES PEER-REVIEWED CLINICAL PUBLICATION EVALUATING THE SAFETY OF RENUVION FOLLOWING LIPOSUCTION IN MULTIPLE AREAS OF THE BODY	23/01	AQ
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body	22/01	BU
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results	08/01	BU
Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer	28/11	BU
Apyx: Q3 Earnings Snapshot	09/11	AQ
Apyx Medical Corporation Announces New Debt Facility with Perceptive Advisors	09/11	BU
Apyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook	09/11	BU
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November	07/11	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Apyx Medical Corp Nasdaq

Equities

US03837C1062

Press Releases

Filters